✦ LIBER ✦

Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subjects

✍ Scribed by H. Katsuki; C. Nakamura; K. Arimori; S. Fujiyama; M. Nakano

Publisher: Springer
Year: 1997
Tongue: English
Weight: 191 KB
Volume: 52
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s002280050307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship between fluvoxamine pharmac

Relationship between fluvoxamine pharmacokinetics and CYP2D6/CYP2C19 phenotype polymorphisms

✍ O. Spigset; K. Granberg; S. Hägg; Å. Norström; R. Dahlqvist 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 155 KB

Influence of rabeprazole and lansoprazol

Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients

✍ Masatomo Miura; Kazuyuki Inoue; Hideaki Kagaya; Shigeru Satoh; Hitoshi Tada; Yos 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

Genetic polymorphism of CYP2D6 in North

Genetic polymorphism of CYP2D6 in North Indian subjects

✍ V. Lamba; J. K. Lamba; J. B. Dilawari; K. K. Kohli 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 89 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity

✍ T. Fukasawa; N. Yasui–Furukori; A. Suzuki; Y. Inoue; T. Tateishi; K. Otani 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 103 KB

Genetic polymorphism of debrisoquine (CY

Genetic polymorphism of debrisoquine (CYP2D6) and proguanil (CYP2C19) in South Pacific Polynesian populations

✍ S. Wanwimolruk; S. Bhawan; P. F. Coville; S. C. W. Chalcroft 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 170 KB

Influence of CYP2C19 genotype on the pha

Influence of CYP2C19 genotype on the pharmacokinetics of R483, a CYP2C19 substrate, in healthy subjects and type 2 diabetes patients

✍ Katrijn Bogman; Mariabeth Silkey; Siew Pheng Chan; Brian Tomlinson; Cornelia Web 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 216 KB